Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.
2.

High-Density Lipoprotein - A Hero, a Mirage, or a Witness?

Sviridov D.

Front Cardiovasc Med. 2014 Nov 14;1:9. doi: 10.3389/fcvm.2014.00009. eCollection 2014. Review.

3.

The emergence of sedentary behaviour physiology and its effects on the cardiometabolic profile in young and older adults.

Ryan DJ, Stebbings GK, Onambele GL.

Age (Dordr). 2015 Oct;37(5):89. doi: 10.1007/s11357-015-9832-7. Epub 2015 Aug 28. Review.

4.

Combined effects of a high-fat diet and chronic valproic acid treatment on hepatic steatosis and hepatotoxicity in rats.

Zhang LF, Liu LS, Chu XM, Xie H, Cao LJ, Guo C, A JY, Cao B, Li MJ, Wang GJ, Hao HP.

Acta Pharmacol Sin. 2014 Mar;35(3):363-72. doi: 10.1038/aps.2013.135. Epub 2014 Jan 20.

5.

Evidence for the presence of lipid-free monomolecular apolipoprotein A-1 in plasma.

Miyazaki O, Ogihara J, Fukamachi I, Kasumi T.

J Lipid Res. 2014 Feb;55(2):214-25. doi: 10.1194/jlr.M041038. Epub 2013 Dec 4.

6.

Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations.

Holleboom AG, Daniil G, Fu X, Zhang R, Hovingh GK, Schimmel AW, Kastelein JJ, Stroes ES, Witztum JL, Hutten BA, Tsimikas S, Hazen SL, Chroni A, Kuivenhoven JA.

Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):3066-75. doi: 10.1161/ATVBAHA.112.255711. Epub 2012 Sep 27.

7.

Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.

Rosenson RS, Brewer HB Jr, Davidson WS, Fayad ZA, Fuster V, Goldstein J, Hellerstein M, Jiang XC, Phillips MC, Rader DJ, Remaley AT, Rothblat GH, Tall AR, Yvan-Charvet L.

Circulation. 2012 Apr 17;125(15):1905-19. doi: 10.1161/CIRCULATIONAHA.111.066589. Review. No abstract available.

8.

Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemia.

Orsoni A, Villard EF, Bruckert E, Robillard P, Carrie A, Bonnefont-Rousselot D, Chapman MJ, Dallinga-Thie GM, Le Goff W, Guerin M.

J Lipid Res. 2012 Apr;53(4):767-75. doi: 10.1194/jlr.M024141. Epub 2012 Feb 15.

9.

Chronic myeloid leukemia patients sensitive and resistant to imatinib treatment show different metabolic responses.

A J, Qian S, Wang G, Yan B, Zhang S, Huang Q, Ni L, Zha W, Liu L, Cao B, Hong M, Wu H, Lu H, Shi J, Li M, Li J.

PLoS One. 2010 Oct 8;5(10):e13186. doi: 10.1371/journal.pone.0013186.

10.

Postprandial lipemia enhances the capacity of large HDL2 particles to mediate free cholesterol efflux via SR-BI and ABCG1 pathways in type IIB hyperlipidemia.

Julia Z, Duchene E, Fournier N, Bellanger N, Chapman MJ, Le Goff W, Guerin M.

J Lipid Res. 2010 Nov;51(11):3350-8. doi: 10.1194/jlr.P009746. Epub 2010 Aug 16.

11.

Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes.

Vergès B, Florentin E, Baillot-Rudoni S, Petit JM, Brindisi MC, Pais de Barros JP, Lagrost L, Gambert P, Duvillard L.

J Lipid Res. 2009 Jun;50(6):1209-15. doi: 10.1194/jlr.P800040-JLR200. Epub 2009 Jan 22.

12.
13.

Metabolism of high density lipoproteins in liver cancer.

Jiang JT, Xu N, Wu CP.

World J Gastroenterol. 2007 Jun 21;13(23):3159-63. Review.

14.

Lipids changes in liver cancer.

Jiang JT, Xu N, Zhang XY, Wu CP.

J Zhejiang Univ Sci B. 2007 Jun;8(6):398-409. Review.

15.

HDL enhances oxidation of LDL in vitro in both men and women.

Solakivi T, Jaakkola O, Salomäki A, Peltonen N, Metso S, Lehtimäki T, Jokela H, Nikkari ST.

Lipids Health Dis. 2005 Oct 20;4:25.

16.

HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner.

Gong M, Wilson M, Kelly T, Su W, Dressman J, Kincer J, Matveev SV, Guo L, Guerin T, Li XA, Zhu W, Uittenbogaard A, Smart EJ.

J Clin Invest. 2003 May;111(10):1579-87.

Supplemental Content

Support Center